![Ton Logtenberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ton Logtenberg
Vorsitzender bei
Synox Therapeutics Ltd.
Profil
Ton Logtenberg was the founder of Crucell NV, founded in 2000, where he held the title of Chief Scientific Officer & Executive VP from 2000 to 2003.
He was also the founder of Merus NV, founded in 2003, where he served as President, Chief Executive Officer & Director.
Currently, Dr. Logtenberg holds several positions.
He is the Chairman of Mestag Therapeutics Ltd. since 2022.
He is also the Non-Executive Chairman of Synox Therapeutics Ltd. since 2021.
Additionally, he serves as the Director of Jenner Vaccine Foundation since 2008 and the Director of Utrecht Science Park since 2014.
Furthermore, Dr. Logtenberg is a Venture Partner at Forbion Capital Partners Management Holding BV since 2022 and a Member-Supervisory Board at Hubrecht Organoid Technology Foundation since 2018.
Dr. Logtenberg has previously worked as an Independent Non-Executive Director at Forbion European Acquisition Corp.
and as a Professor at the University of Utrecht.
Dr. Logtenberg obtained a doctorate degree from the University of Utrecht.
Aktive Positionen von Ton Logtenberg
| Unternehmen | Position | Beginn |
|---|---|---|
Utrecht Science Park | Direktor/Vorstandsmitglied | 01.11.2014 |
Jenner Vaccine Foundation | Direktor/Vorstandsmitglied | 01.01.2008 |
Hubrecht Organoid Technology Foundation | Direktor/Vorstandsmitglied | 01.08.2018 |
Synox Therapeutics Ltd.
 Synox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biopharmaceutical company | Vorsitzender | 27.07.2021 |
Mestag Therapeutics Ltd.
 Mestag Therapeutics Ltd. Financial ConglomeratesFinance Provides investment services | Vorsitzender | 20.12.2022 |
Ehemalige bekannte Positionen von Ton Logtenberg
| Unternehmen | Position | Ende |
|---|---|---|
| MERUS N.V. | Vorstandsvorsitzender | 31.12.2019 |
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Develops, produces and markets vaccines, proteins and antibodies | Gründer | 01.11.2003 |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Private Equity Investor | - |
| ENGE HLDGNPV | Direktor/Vorstandsmitglied | - |
| ░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Ton Logtenberg
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Develops, produces and markets vaccines, proteins and antibodies | Health Technology |
University of Utrecht
 University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Finance |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Jenner Vaccine Foundation | |
Utrecht Science Park | |
Hubrecht Organoid Technology Foundation | |
Mestag Therapeutics Ltd.
Mestag Therapeutics Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Synox Therapeutics Ltd.
Synox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biopharmaceutical company | Health Technology |
Forbion European Acquisition Corp.
 Forbion European Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
